A detailed history of Magellan Asset Management LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Magellan Asset Management LTD holds 2,411,828 shares of NVO stock, worth $253 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
2,411,828
Previous 1,903,280 26.72%
Holding current value
$253 Million
Previous $272 Million 5.71%
% of portfolio
2.86%
Previous 2.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $60.6 Million - $74 Million
508,548 Added 26.72%
2,411,828 $287 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $234 Million - $280 Million
1,903,280 New
1,903,280 $272 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Magellan Asset Management LTD Portfolio

Follow Magellan Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magellan Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Magellan Asset Management LTD with notifications on news.